Cardiol Therapeutics Inc.
IPOHome - Cardiol Therapeutics
Public · Oakville, Canada · Founded 2017 · $24.5M raised
- Headquarters
- Oakville
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- cardiolrx.com
- Total Funding
- $24.5M
- Last Round
- $13.5M Venture RoundJan 2026
- Rounds
- 2
- Type
- Public
About
Late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease.
Summary
Cardiol Therapeutics Inc. is a Biotech company based in Oakville, Canada, founded in 2017. It has raised $24.5M in total across 2 rounds, most recently a $13.5M Venture Round round in Jan 2026. Investors include Insiders Ventures.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...